Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer

Matteo Ligorio(Massachusetts General Hospital), Srinjoy Sil(Massachusetts General Hospital), Jose Malagon-Lopez(Massachusetts General Hospital), Linda T. Nieman(Massachusetts General Hospital), Sandra Misale(Massachusetts General Hospital), Mauro Di Pilato(Massachusetts General Hospital), Richard Y. Ebright(Massachusetts General Hospital), Murat Karabacak(Harvard University), Anupriya S. Kulkarni(Massachusetts General Hospital), Ann Liu(Massachusetts General Hospital), Nicole Vincent Jordan(Massachusetts General Hospital), Joseph W. Franses(Massachusetts General Hospital), Julia Philipp(Massachusetts General Hospital), Johannes Kreuzer(Massachusetts General Hospital), Niyati Desai(Massachusetts General Hospital), Kshitij S. Arora(Massachusetts General Hospital), Mihir Rajurkar(Massachusetts General Hospital), E. Philip Horwitz(Massachusetts General Hospital), Azfar Neyaz(Massachusetts General Hospital), Eric C. Tai(Massachusetts General Hospital), Neelima K. C. Magnus(Massachusetts General Hospital), Kevin D. Vo(Massachusetts General Hospital), Chittampalli N. Yashaswini(Massachusetts General Hospital), Francesco Marangoni(Massachusetts General Hospital), Myriam Boukhali(Massachusetts General Hospital), Jackson P. Fatherree(Massachusetts General Hospital), Leah J. Damon(Massachusetts General Hospital), Kristina Xega(Massachusetts General Hospital), Rushil Desai(Massachusetts General Hospital), Melissa Choz(Massachusetts General Hospital), Francesca Bersani(Massachusetts General Hospital), Adam Langenbucher(Massachusetts General Hospital), Vishal Thapar(Massachusetts General Hospital), Robert Morris(Massachusetts General Hospital), Ulrich F. Wellner(Universitäres Kinderwunschzentrum Lübeck), Oliver Schilling(University Medical Center Freiburg), Michael S. Lawrence(Massachusetts General Hospital), Andrew S. Liss(Massachusetts General Hospital), Miguel N. Rivera(Massachusetts General Hospital), Vikram Deshpande(Massachusetts General Hospital), Cyril H. Benes(Massachusetts General Hospital), Shyamala Maheswaran(Massachusetts General Hospital), Daniel A. Haber(Howard Hughes Medical Institute), Carlos Fernández‐del‐Castillo(Massachusetts General Hospital), Cristina R. Ferrone(Massachusetts General Hospital), Wilhelm Haas(Massachusetts General Hospital), Martin J. Aryee(Harvard University), David T. Ting(Massachusetts General Hospital)
Cited by 532Open Access
Full Text

Abstract

Single-cell technologies have described heterogeneity across tissues, but the spatial distribution and forces that drive single-cell phenotypes have not been well defined. Combining single-cell RNA and protein analytics in studying the role of stromal cancer-associated fibroblasts (CAFs) in modulating heterogeneity in pancreatic cancer (pancreatic ductal adenocarcinoma [PDAC]) model systems, we have identified significant single-cell population shifts toward invasive epithelial-to-mesenchymal transition (EMT) and proliferative (PRO) phenotypes linked with mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription 3 (STAT3) signaling. Using high-content digital imaging of RNA in situ hybridization in 195 PDAC tumors, we quantified these EMT and PRO subpopulations in 319,626 individual cancer cells that can be classified within the context of distinct tumor gland "units." Tumor gland typing provided an additional layer of intratumoral heterogeneity that was associated with differences in stromal abundance and clinical outcomes. This demonstrates the impact of the stroma in shaping tumor architecture by altering inherent patterns of tumor glands in human PDAC.


Related Papers

No related papers found

Powered by citation graph analysis